Exact Sciences
EXAS
#1541
Rank
โ‚น934.71 B
Marketcap
โ‚น5,050
Share price
5.86%
Change (1 day)
-17.40%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น300.82 Billion

According to Exact Sciences's latest financial reports the company's total liabilities are โ‚น300.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น276.88 B5.1%
2022-12-31โ‚น263.45 B7.35%
2021-12-31โ‚น245.41 B24.77%
2020-12-31โ‚น196.69 B126.52%
2019-12-31โ‚น86.83 B47.3%
2018-12-31โ‚น58.95 B1081.5%
2017-12-31โ‚น4.98 B75.88%
2016-12-31โ‚น2.83 B14.83%
2015-12-31โ‚น2.47 B63.5%
2014-12-31โ‚น1.51 B116.22%
2013-12-31โ‚น0.69 B-5.63%
2012-12-31โ‚น0.74 B4.01%
2011-12-31โ‚น0.71 B-5.21%
2010-12-31โ‚น0.75 B-17.73%
2009-12-31โ‚น0.91 B128%
2008-12-31โ‚น0.40 B22.83%
2007-12-31โ‚น0.32 B-17.39%
2006-12-31โ‚น0.39 B-33.69%
2005-12-31โ‚น0.59 B-24.2%
2004-12-31โ‚น0.78 B-23.2%
2003-12-31โ‚น1.02 B81.63%
2002-12-31โ‚น0.56 B182.23%
2001-12-31โ‚น0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น29.72 B-90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.41 B-97.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.85 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.173 T 1,619.69%๐Ÿ‡ซ๐Ÿ‡ท France